HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bisgaier, C. L. Articles by Glickman, R. M. Search for Related Content PubMed PubMed Citation Articles by Bisgaier, C. L. Articles by Glickman, R. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 28, 693-703, Copyright © 1987 by Lipid Research, Inc.

ARTICLES

Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma

CL Bisgaier, OP Sachdev, ES Lee, KJ Williams, CB Blum and RM Glickman

The effect of cholesterol esterification on the distribution of apoA-IV in human plasma was investigated. Human plasma was incubated in the presence or absence of the lecithin:cholesterol acyltransferase (LCAT) inhibitor 5,5-dithiobis(2-nitrobenzoic acid) (DTNB) and immediately fractionated by 6% agarose column chromatography. Fractions were monitored for apoA-IV, apoE, and apoA-I by radioimmunoassay (RIA). Incubation resulted in an elevated plasma concentration of cholesteryl ester and in an altered distribution of apoA-IV. After incubation apoA- IV eluted in the ordinarily apoA-IV-poor fractions of plasma that contain small VLDL particles, LDL, and HDL2. Inclusion of DTNB during the incubation resulted in some enlargement of HDL; however, both cholesterol esterification and lipoprotein binding of apoA-IV were inhibited. Addition of DTNB to plasma after incubation and prior to gel filtration had no effect on the apoA-IV distribution when the lipoproteins were immediately fractionated. Fasting plasma apoE was distributed in two or three peaks; in some plasmas there was a small peak that eluted with the column void volume, and, in all plasmas, there were larger peaks that eluted with the VLDL-LDL region and HDL2. Incubation resulted in displacement of HDL apoE to larger lipoproteins and this effect was observed in the presence or absence of DTNB. ApoA-I was distributed in a single broad peak that eluted in the region of HDL and the gel-filtered distribution was unaffected by incubation either in the presence or absence of DTNB. Incubation of plasma that was previously heated to 56 degrees C to inactivate LCAT resulted in no additional movement of apoA-IV onto lipoproteins, unless purified LCAT was present during incubation. The addition of heat-inactivated LCAT to the incubation, had no effect on movement of apoA-IV. These data suggest that human apoA-IV redistribution from the lipoprotein-free fraction to lipoprotein particles appears to be dependent on LCAT action. The mechanism responsible for the increased binding of apoA-IV to the surface of lipoproteins when LCAT acts may involve the generation of "gaps" in the lipoprotein surface due to the consumption of substrate from the surface and additional enlargement of the core. ApoA-IV may bind to these "gaps," where the packing density of the phospholipid head groups is reduced.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Ezeh, M. Haiman, H. F. Alber, B. Kunz, B. Paulweber, A. Lingenhel, H.-G. Kraft, F. Weidinger, O. Pachinger, H. Dieplinger, et al. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls J. Lipid Res., August 1, 2003; 44(8): 1523 - 1529. [Abstract] [Full Text] [PDF]

				R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, A. R. Tall, and A. Steinmetz Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein J. Biol. Chem., June 7, 2002; 277(24): 21549 - 21553. [Abstract] [Full Text] [PDF]

				R. B. Weinberg, V. R. Cook, J. A. DeLozier, and G. S. Shelness Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface J. Lipid Res., September 1, 2000; 41(9): 1419 - 1427. [Abstract] [Full Text]

				T. J. Kalogeris, R. G. Painter, and V. R. Holden Ileal Lipid Infusion Stimulates Jejunal Synthesis of Apolipoprotein A-IV Without Affecting mRNA Levels Experimental Biology and Medicine, February 1, 2000; 223(2): 198 - 202. [Abstract] [Full Text]

				T. J. Kalogeris, X. Qin, W. Y. Chey, and P. Tso PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G668 - G674. [Abstract] [Full Text] [PDF]

				G. T. Shwaery, J. A. Vita, and J. F. Keaney Jr Antioxidant Protection of LDL by Physiological Concentrations of 17ß-Estradiol : Requirement for Estradiol Modification Circulation, March 18, 1997; 95(6): 1378 - 1385. [Abstract] [Full Text]

				T. J. Kalogeris, M.-D. Rodriguez, and P. Tso Control of Synthesis and Secretion of Intestinal Apolipoprotein A-IV by Lipid J. Nutr., March 1, 1997; 127(3): 537 - 537. [Abstract] [Full Text]

				A. von Eckardstein, Y. Huang, S. Wu, A. S. Sarmadi, S. Schwarz, A. Steinmetz, and G. Assmann Lipoproteins Containing Apolipoprotein A-IV but Not Apolipoprotein A-I Take Up and Esterify Cell-Derived Cholesterol in Plasma Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1755 - 1763. [Abstract] [Full Text]